| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 67 | 2024 | 5034 | 4.200 |
Why?
|
| Catheter Ablation | 51 | 2024 | 2758 | 3.690 |
Why?
|
| Cardiac Resynchronization Therapy | 20 | 2019 | 531 | 3.550 |
Why?
|
| Cardiac Pacing, Artificial | 21 | 2020 | 845 | 2.190 |
Why?
|
| Electric Countershock | 9 | 2023 | 534 | 2.120 |
Why?
|
| Defibrillators, Implantable | 20 | 2023 | 1440 | 2.050 |
Why?
|
| Anti-Arrhythmia Agents | 12 | 2019 | 789 | 1.770 |
Why?
|
| Heart Failure | 35 | 2021 | 10900 | 1.620 |
Why?
|
| Atrial Appendage | 9 | 2024 | 283 | 1.590 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 7 | 2018 | 124 | 1.550 |
Why?
|
| Heart Ventricles | 24 | 2019 | 3821 | 1.470 |
Why?
|
| Electrocardiography | 27 | 2019 | 6442 | 1.430 |
Why?
|
| Body Surface Potential Mapping | 12 | 2015 | 238 | 1.410 |
Why?
|
| Pulmonary Veins | 14 | 2024 | 761 | 1.400 |
Why?
|
| Heart Conduction System | 12 | 2020 | 1047 | 1.090 |
Why?
|
| Arrhythmias, Cardiac | 14 | 2022 | 2268 | 1.080 |
Why?
|
| Death, Sudden, Cardiac | 7 | 2023 | 1541 | 1.010 |
Why?
|
| Internal Medicine | 2 | 2021 | 1009 | 0.930 |
Why?
|
| Pacemaker, Artificial | 9 | 2019 | 816 | 0.930 |
Why?
|
| Defibrillators | 1 | 2023 | 37 | 0.890 |
Why?
|
| Heart Atria | 12 | 2019 | 1357 | 0.880 |
Why?
|
| Ventricular Fibrillation | 3 | 2018 | 538 | 0.880 |
Why?
|
| Heart Rate | 12 | 2020 | 4091 | 0.820 |
Why?
|
| Brugada Syndrome | 2 | 2015 | 97 | 0.810 |
Why?
|
| Tachycardia, Ventricular | 8 | 2021 | 1273 | 0.770 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 10 | 2019 | 493 | 0.700 |
Why?
|
| Ventricular Dysfunction | 1 | 2019 | 143 | 0.660 |
Why?
|
| Specialty Boards | 1 | 2020 | 227 | 0.660 |
Why?
|
| Atrioventricular Block | 1 | 2019 | 120 | 0.630 |
Why?
|
| Anticoagulants | 10 | 2024 | 4599 | 0.610 |
Why?
|
| Certification | 1 | 2021 | 424 | 0.610 |
Why?
|
| Ventricular Remodeling | 5 | 2019 | 1224 | 0.600 |
Why?
|
| Chaperonin 60 | 1 | 2016 | 103 | 0.570 |
Why?
|
| Primary Prevention | 2 | 2023 | 1167 | 0.560 |
Why?
|
| Education, Medical, Continuing | 1 | 2020 | 840 | 0.510 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 720 | 0.500 |
Why?
|
| Cardiography, Impedance | 1 | 2014 | 41 | 0.500 |
Why?
|
| Treatment Outcome | 56 | 2024 | 63114 | 0.480 |
Why?
|
| Dextrocardia | 2 | 2010 | 37 | 0.480 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 690 | 0.470 |
Why?
|
| Long QT Syndrome | 2 | 2010 | 453 | 0.460 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2019 | 2073 | 0.460 |
Why?
|
| Bundle-Branch Block | 2 | 2015 | 270 | 0.450 |
Why?
|
| Transducers, Pressure | 3 | 2019 | 56 | 0.440 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2019 | 3537 | 0.430 |
Why?
|
| Surgery, Computer-Assisted | 6 | 2015 | 1018 | 0.420 |
Why?
|
| Humans | 154 | 2024 | 744343 | 0.410 |
Why?
|
| Electrodes, Implanted | 9 | 2012 | 824 | 0.410 |
Why?
|
| Stroke | 10 | 2024 | 9981 | 0.400 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.400 |
Why?
|
| Angioplasty, Balloon, Laser-Assisted | 1 | 2011 | 25 | 0.400 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 414 | 0.390 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2013 | 4042 | 0.390 |
Why?
|
| Societies, Medical | 1 | 2023 | 3743 | 0.380 |
Why?
|
| Coronary Thrombosis | 2 | 2011 | 495 | 0.380 |
Why?
|
| Epicardial Mapping | 1 | 2010 | 57 | 0.380 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2011 | 57 | 0.380 |
Why?
|
| Electrocardiography, Ambulatory | 5 | 2020 | 585 | 0.380 |
Why?
|
| Fluoroscopy | 3 | 2013 | 924 | 0.380 |
Why?
|
| Atrial Flutter | 4 | 2017 | 263 | 0.370 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2010 | 66 | 0.370 |
Why?
|
| Aged | 72 | 2024 | 163280 | 0.370 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 996 | 0.370 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 546 | 0.370 |
Why?
|
| Cardiomyopathies | 5 | 2019 | 1912 | 0.360 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 137 | 0.360 |
Why?
|
| Hypothyroidism | 1 | 2015 | 658 | 0.350 |
Why?
|
| Therapeutic Irrigation | 3 | 2021 | 301 | 0.350 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2011 | 173 | 0.350 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2011 | 125 | 0.350 |
Why?
|
| Myocardial Ischemia | 8 | 2020 | 2148 | 0.340 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2000 | 494 | 0.330 |
Why?
|
| Male | 102 | 2024 | 350118 | 0.330 |
Why?
|
| Saphenous Vein | 1 | 2012 | 532 | 0.330 |
Why?
|
| Aneurysm | 1 | 2012 | 339 | 0.320 |
Why?
|
| Esophagus | 5 | 2013 | 1019 | 0.320 |
Why?
|
| Bradycardia | 1 | 2010 | 307 | 0.310 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2015 | 1442 | 0.310 |
Why?
|
| Fever | 1 | 2015 | 1616 | 0.300 |
Why?
|
| Heart Injuries | 3 | 2019 | 210 | 0.300 |
Why?
|
| Body Temperature | 4 | 2015 | 777 | 0.300 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2010 | 314 | 0.290 |
Why?
|
| Angina Pectoris, Variant | 1 | 2006 | 55 | 0.290 |
Why?
|
| Prosthesis Implantation | 6 | 2017 | 642 | 0.290 |
Why?
|
| Monitoring, Physiologic | 3 | 2019 | 1738 | 0.290 |
Why?
|
| Follow-Up Studies | 23 | 2019 | 39050 | 0.280 |
Why?
|
| Radiation Dosage | 3 | 2013 | 1928 | 0.280 |
Why?
|
| Female | 92 | 2024 | 380194 | 0.280 |
Why?
|
| Pericardium | 1 | 2011 | 667 | 0.280 |
Why?
|
| Echocardiography | 11 | 2019 | 5102 | 0.280 |
Why?
|
| Cryosurgery | 1 | 2010 | 453 | 0.270 |
Why?
|
| Equipment Design | 9 | 2018 | 3582 | 0.260 |
Why?
|
| Patient Readmission | 1 | 2019 | 3114 | 0.260 |
Why?
|
| Coronary Artery Bypass | 2 | 2012 | 2289 | 0.250 |
Why?
|
| Heart | 5 | 2019 | 4467 | 0.250 |
Why?
|
| Ventricular Premature Complexes | 2 | 2021 | 111 | 0.250 |
Why?
|
| Prognosis | 14 | 2021 | 29063 | 0.250 |
Why?
|
| Middle Aged | 64 | 2023 | 213383 | 0.250 |
Why?
|
| Disease Management | 2 | 2016 | 2459 | 0.250 |
Why?
|
| Torsades de Pointes | 1 | 2005 | 78 | 0.250 |
Why?
|
| Stroke Volume | 8 | 2019 | 5007 | 0.250 |
Why?
|
| Incidence | 12 | 2020 | 20947 | 0.240 |
Why?
|
| Sensitivity and Specificity | 12 | 2018 | 14722 | 0.240 |
Why?
|
| Thromboembolism | 2 | 2023 | 986 | 0.240 |
Why?
|
| Radiography, Thoracic | 3 | 2010 | 1265 | 0.240 |
Why?
|
| Heart Block | 1 | 2005 | 410 | 0.230 |
Why?
|
| Postoperative Complications | 10 | 2020 | 15295 | 0.230 |
Why?
|
| Computer Simulation | 1 | 2017 | 6196 | 0.230 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1912 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.220 |
Why?
|
| Myocardial Contraction | 2 | 2005 | 1585 | 0.220 |
Why?
|
| Algorithms | 9 | 2019 | 13881 | 0.220 |
Why?
|
| Hospitalization | 9 | 2021 | 10262 | 0.220 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2019 | 1534 | 0.220 |
Why?
|
| Angina Pectoris | 1 | 2006 | 977 | 0.210 |
Why?
|
| Physicians | 1 | 2020 | 4567 | 0.210 |
Why?
|
| Hemodynamics | 2 | 2018 | 4199 | 0.210 |
Why?
|
| Reproducibility of Results | 12 | 2018 | 19905 | 0.210 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 1813 | 0.210 |
Why?
|
| Risk Assessment | 14 | 2020 | 23338 | 0.200 |
Why?
|
| Feasibility Studies | 9 | 2015 | 5078 | 0.200 |
Why?
|
| Heart Transplantation | 5 | 2015 | 3110 | 0.200 |
Why?
|
| Swine | 10 | 2019 | 5917 | 0.190 |
Why?
|
| Coronary Angiography | 6 | 2010 | 4577 | 0.190 |
Why?
|
| United States | 16 | 2024 | 69872 | 0.190 |
Why?
|
| Treatment Failure | 4 | 2019 | 2618 | 0.190 |
Why?
|
| Action Potentials | 5 | 2020 | 1806 | 0.190 |
Why?
|
| Equipment Failure | 4 | 2011 | 578 | 0.190 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2020 | 39 | 0.190 |
Why?
|
| Retrospective Studies | 27 | 2022 | 77449 | 0.190 |
Why?
|
| Situs Inversus | 2 | 2010 | 64 | 0.190 |
Why?
|
| Atherosclerosis | 1 | 2016 | 3445 | 0.190 |
Why?
|
| Hospital Mortality | 6 | 2021 | 5317 | 0.190 |
Why?
|
| Heart Arrest | 1 | 2010 | 1470 | 0.180 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2020 | 1265 | 0.180 |
Why?
|
| Risk Factors | 19 | 2021 | 72290 | 0.180 |
Why?
|
| Aged, 80 and over | 24 | 2021 | 57776 | 0.170 |
Why?
|
| Ischemic Attack, Transient | 2 | 2018 | 935 | 0.170 |
Why?
|
| Software | 1 | 2013 | 4443 | 0.160 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 2029 | 0.160 |
Why?
|
| Comorbidity | 7 | 2020 | 10388 | 0.160 |
Why?
|
| Prevalence | 6 | 2021 | 15226 | 0.160 |
Why?
|
| Septal Occluder Device | 1 | 2019 | 128 | 0.160 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 2765 | 0.160 |
Why?
|
| Nuclear Localization Signals | 1 | 1998 | 80 | 0.160 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 236 | 0.160 |
Why?
|
| Drug Design | 2 | 2014 | 1076 | 0.160 |
Why?
|
| Telomerase | 1 | 2003 | 730 | 0.160 |
Why?
|
| Electrodes | 2 | 2018 | 619 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2020 | 719 | 0.150 |
Why?
|
| Length of Stay | 4 | 2019 | 6309 | 0.150 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2019 | 263 | 0.150 |
Why?
|
| Endocardium | 1 | 2018 | 263 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2015 | 20129 | 0.150 |
Why?
|
| Prospective Studies | 14 | 2019 | 53288 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 440 | 0.140 |
Why?
|
| Predictive Value of Tests | 9 | 2018 | 15076 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4245 | 0.140 |
Why?
|
| Critical Pathways | 2 | 2019 | 476 | 0.140 |
Why?
|
| Warfarin | 3 | 2019 | 1496 | 0.130 |
Why?
|
| Cell Nucleus | 3 | 2002 | 2969 | 0.130 |
Why?
|
| Phrenic Nerve | 1 | 2015 | 79 | 0.130 |
Why?
|
| Secondary Prevention | 2 | 2012 | 1530 | 0.130 |
Why?
|
| Patient Care Team | 2 | 2019 | 2531 | 0.130 |
Why?
|
| Data Mining | 1 | 2020 | 537 | 0.130 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 11727 | 0.120 |
Why?
|
| Subtraction Technique | 2 | 2008 | 525 | 0.120 |
Why?
|
| Early Diagnosis | 2 | 2016 | 1184 | 0.120 |
Why?
|
| Air Pollution, Radioactive | 1 | 2013 | 10 | 0.120 |
Why?
|
| Time Factors | 15 | 2020 | 40075 | 0.120 |
Why?
|
| Emergency Service, Hospital | 5 | 2019 | 7659 | 0.120 |
Why?
|
| Ventricular Function, Left | 3 | 2018 | 3670 | 0.120 |
Why?
|
| Equipment Failure Analysis | 3 | 2013 | 868 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2020 | 1210 | 0.120 |
Why?
|
| Respiratory System | 1 | 2017 | 557 | 0.110 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2020 | 274 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2014 | 6538 | 0.110 |
Why?
|
| Heart Valve Prolapse | 1 | 2012 | 3 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2017 | 767 | 0.110 |
Why?
|
| Temperature | 2 | 2018 | 2206 | 0.110 |
Why?
|
| Radiation Monitoring | 1 | 2013 | 98 | 0.110 |
Why?
|
| Educational Status | 1 | 2020 | 2540 | 0.110 |
Why?
|
| Electric Impedance | 2 | 2014 | 729 | 0.110 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 12245 | 0.110 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 15165 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 2 | 2015 | 1965 | 0.110 |
Why?
|
| Myocardium | 3 | 2010 | 4776 | 0.100 |
Why?
|
| Coronary Vessels | 4 | 2007 | 3107 | 0.100 |
Why?
|
| Disease Progression | 4 | 2016 | 13284 | 0.100 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2011 | 69 | 0.100 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2011 | 31 | 0.100 |
Why?
|
| Endpoint Determination | 1 | 2014 | 601 | 0.100 |
Why?
|
| Electric Power Supplies | 1 | 2011 | 99 | 0.100 |
Why?
|
| Echocardiography, Doppler | 4 | 2012 | 935 | 0.100 |
Why?
|
| Hyponatremia | 1 | 2014 | 298 | 0.100 |
Why?
|
| Animals | 21 | 2020 | 168757 | 0.100 |
Why?
|
| Sex Factors | 4 | 2015 | 10397 | 0.100 |
Why?
|
| Cicatrix | 1 | 2017 | 764 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2019 | 944 | 0.100 |
Why?
|
| Quinidine | 1 | 2010 | 57 | 0.100 |
Why?
|
| Massachusetts | 7 | 2013 | 8663 | 0.100 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 126 | 0.100 |
Why?
|
| Catheters | 2 | 2011 | 425 | 0.100 |
Why?
|
| Survival Rate | 4 | 2019 | 12788 | 0.090 |
Why?
|
| Bundle of His | 1 | 2010 | 87 | 0.090 |
Why?
|
| Registries | 4 | 2023 | 8089 | 0.090 |
Why?
|
| Tomography, Spiral Computed | 1 | 2012 | 280 | 0.090 |
Why?
|
| Pulmonary Atelectasis | 1 | 2011 | 145 | 0.090 |
Why?
|
| Circadian Rhythm | 3 | 2019 | 2624 | 0.090 |
Why?
|
| Histamine Antagonists | 1 | 2010 | 93 | 0.090 |
Why?
|
| Patient Selection | 2 | 2017 | 4215 | 0.090 |
Why?
|
| Sodium Channel Blockers | 1 | 2010 | 176 | 0.090 |
Why?
|
| Antithrombins | 1 | 2012 | 304 | 0.090 |
Why?
|
| Administration, Oral | 2 | 2019 | 3913 | 0.090 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2010 | 242 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1831 | 0.090 |
Why?
|
| Calmodulin | 3 | 2000 | 209 | 0.090 |
Why?
|
| Models, Animal | 2 | 2018 | 2171 | 0.080 |
Why?
|
| Cryotherapy | 1 | 2009 | 155 | 0.080 |
Why?
|
| Coronary Sinus | 1 | 2009 | 87 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2019 | 2616 | 0.080 |
Why?
|
| Adult | 21 | 2021 | 214055 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 3508 | 0.080 |
Why?
|
| Dogs | 1 | 2013 | 3912 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2018 | 1859 | 0.080 |
Why?
|
| Patient Admission | 1 | 2016 | 1380 | 0.080 |
Why?
|
| Arrhythmia, Sinus | 1 | 2008 | 56 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1177 | 0.080 |
Why?
|
| Tachycardia | 1 | 2010 | 619 | 0.080 |
Why?
|
| Suction | 1 | 2009 | 267 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1420 | 0.080 |
Why?
|
| Calcium | 7 | 2019 | 5756 | 0.080 |
Why?
|
| Aging | 3 | 2003 | 8664 | 0.080 |
Why?
|
| Sus scrofa | 2 | 2020 | 437 | 0.080 |
Why?
|
| Heart-Assist Devices | 2 | 2015 | 1194 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2012 | 1184 | 0.080 |
Why?
|
| Syncope | 1 | 2010 | 429 | 0.080 |
Why?
|
| Risk Adjustment | 1 | 2011 | 594 | 0.070 |
Why?
|
| Tachycardia, Sinus | 1 | 2006 | 42 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2021 | 8642 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6489 | 0.070 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 195 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2011 | 35421 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2014 | 1073 | 0.070 |
Why?
|
| Terfenadine | 1 | 2005 | 15 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2016 | 1938 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2019 | 3209 | 0.070 |
Why?
|
| Bronchoscopy | 1 | 2011 | 862 | 0.070 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2009 | 349 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2010 | 1460 | 0.070 |
Why?
|
| Nitroglycerin | 1 | 2006 | 325 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 2014 | 1488 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 5391 | 0.070 |
Why?
|
| Histamine H1 Antagonists | 1 | 2005 | 100 | 0.070 |
Why?
|
| Hospitals | 1 | 2019 | 3952 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4687 | 0.060 |
Why?
|
| Systems Integration | 1 | 2007 | 440 | 0.060 |
Why?
|
| Boston | 3 | 2015 | 9313 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2018 | 12026 | 0.060 |
Why?
|
| Foreign-Body Migration | 1 | 2007 | 222 | 0.060 |
Why?
|
| Antipsychotic Agents | 2 | 2010 | 3057 | 0.060 |
Why?
|
| Psychometrics | 1 | 2014 | 3002 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2020 | 3749 | 0.060 |
Why?
|
| Inpatients | 2 | 2020 | 2518 | 0.060 |
Why?
|
| Recurrence | 4 | 2019 | 8340 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 7279 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2012 | 1058 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 957 | 0.060 |
Why?
|
| Radiography, Interventional | 2 | 2011 | 1095 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2005 | 364 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2013 | 1786 | 0.060 |
Why?
|
| Magnetics | 1 | 2007 | 606 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 1536 | 0.060 |
Why?
|
| Hemothorax | 1 | 2023 | 60 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2000 | 173 | 0.060 |
Why?
|
| Chest Pain | 1 | 2010 | 1114 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2266 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 337 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 1239 | 0.060 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2010 | 1422 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2015 | 2250 | 0.050 |
Why?
|
| Outpatients | 1 | 2010 | 1486 | 0.050 |
Why?
|
| Protamines | 1 | 2023 | 106 | 0.050 |
Why?
|
| Quality of Life | 2 | 2014 | 12804 | 0.050 |
Why?
|
| Veins | 1 | 2007 | 770 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 1416 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2011 | 1161 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 977 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2017 | 6895 | 0.050 |
Why?
|
| Diagnosis, Differential | 4 | 2011 | 12959 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2012 | 2921 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 2 | 2012 | 2337 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2005 | 123 | 0.050 |
Why?
|
| Severity of Illness Index | 5 | 2014 | 15540 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2007 | 1082 | 0.050 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2000 | 49 | 0.050 |
Why?
|
| Acute Disease | 1 | 2011 | 7149 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2538 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 9959 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13989 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2002 | 430 | 0.050 |
Why?
|
| Technology Transfer | 1 | 2020 | 44 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 491 | 0.050 |
Why?
|
| Wound Healing | 1 | 2011 | 2785 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2000 | 171 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 3798 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 12354 | 0.040 |
Why?
|
| Burns | 1 | 2011 | 1815 | 0.040 |
Why?
|
| Radiography | 2 | 2011 | 7023 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2000 | 249 | 0.040 |
Why?
|
| Melatonin | 2 | 1997 | 721 | 0.040 |
Why?
|
| Steam | 1 | 2018 | 31 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 1998 | 18 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2013 | 4234 | 0.040 |
Why?
|
| Serine | 2 | 2002 | 826 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 1998 | 73 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18029 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2019 | 162 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1904 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2005 | 1547 | 0.040 |
Why?
|
| Pulse | 1 | 2018 | 229 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3760 | 0.040 |
Why?
|
| Pericardiocentesis | 2 | 2008 | 74 | 0.040 |
Why?
|
| Reoperation | 3 | 2016 | 4201 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2012 | 10252 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1159 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2019 | 490 | 0.040 |
Why?
|
| Telomere | 1 | 2003 | 910 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2016 | 9146 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2010 | 5985 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2005 | 8436 | 0.040 |
Why?
|
| COS Cells | 1 | 1998 | 1161 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2007 | 1537 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2017 | 330 | 0.030 |
Why?
|
| Hydroquinones | 1 | 1995 | 36 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2017 | 539 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1997 | 231 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2002 | 1640 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 514 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2012 | 2971 | 0.030 |
Why?
|
| Phlebography | 2 | 2007 | 333 | 0.030 |
Why?
|
| Health Status Indicators | 2 | 2011 | 969 | 0.030 |
Why?
|
| Age Factors | 1 | 2012 | 18370 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3507 | 0.030 |
Why?
|
| Materials Testing | 1 | 2018 | 867 | 0.030 |
Why?
|
| Medicare | 2 | 2024 | 6566 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 1723 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 21683 | 0.030 |
Why?
|
| Pilot Projects | 3 | 2013 | 8324 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2010 | 1590 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2020 | 7729 | 0.030 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 1637 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 671 | 0.030 |
Why?
|
| Transfection | 2 | 2002 | 5892 | 0.030 |
Why?
|
| Cost Savings | 1 | 2019 | 926 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 4258 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2886 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 1387 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2505 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 855 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1998 | 871 | 0.030 |
Why?
|
| Seasons | 1 | 2019 | 1493 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 13815 | 0.030 |
Why?
|
| Binding Sites | 2 | 2000 | 6114 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2017 | 691 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2018 | 40561 | 0.030 |
Why?
|
| Chlorides | 1 | 1995 | 667 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 1616 | 0.030 |
Why?
|
| Exercise Test | 1 | 2020 | 2074 | 0.030 |
Why?
|
| Pain | 1 | 2007 | 4986 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6365 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 18111 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 2065 | 0.030 |
Why?
|
| Hypertension | 1 | 2012 | 8480 | 0.030 |
Why?
|
| Depressive Disorder | 2 | 1997 | 3748 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 1783 | 0.020 |
Why?
|
| Radiation | 1 | 2010 | 49 | 0.020 |
Why?
|
| Logistic Models | 1 | 2006 | 13408 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2023 | 3461 | 0.020 |
Why?
|
| Atrial Function | 1 | 2010 | 107 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 1681 | 0.020 |
Why?
|
| Femoral Vein | 1 | 2011 | 159 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2012 | 854 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2011 | 187 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2019 | 1207 | 0.020 |
Why?
|
| Electromagnetic Phenomena | 1 | 2011 | 161 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 2429 | 0.020 |
Why?
|
| Proteins | 1 | 2005 | 6103 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2011 | 390 | 0.020 |
Why?
|
| Punctures | 1 | 2011 | 374 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2011 | 458 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 367 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2011 | 339 | 0.020 |
Why?
|
| Pancreas | 1 | 1995 | 1686 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2708 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 11725 | 0.020 |
Why?
|
| Cardiology | 1 | 2019 | 1668 | 0.020 |
Why?
|
| Radiometry | 1 | 2013 | 800 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2011 | 1014 | 0.020 |
Why?
|
| Needles | 1 | 2011 | 449 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5853 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 958 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 6487 | 0.020 |
Why?
|
| Rupture | 1 | 2008 | 433 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2007 | 211 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1995 | 1177 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2019 | 3313 | 0.020 |
Why?
|
| Apoptosis | 1 | 2003 | 9727 | 0.020 |
Why?
|
| Cardiac Tamponade | 1 | 2007 | 173 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1686 | 0.020 |
Why?
|
| Hippocampus | 1 | 1998 | 3675 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2011 | 1609 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 9648 | 0.020 |
Why?
|
| Troponin T | 1 | 2010 | 754 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2005 | 158 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2011 | 1133 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 11366 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 137 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2005 | 127 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 804 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2010 | 996 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2011 | 1301 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2021 | 12720 | 0.010 |
Why?
|
| Cause of Death | 1 | 2014 | 3584 | 0.010 |
Why?
|
| Device Removal | 1 | 2008 | 656 | 0.010 |
Why?
|
| Transposition of Great Vessels | 1 | 2007 | 588 | 0.010 |
Why?
|
| Ionomycin | 1 | 2002 | 109 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 12208 | 0.010 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2008 | 591 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2007 | 2297 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 2005 | 620 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9849 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2902 | 0.010 |
Why?
|
| Signal Transduction | 3 | 2003 | 23403 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 2000 | 32 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7913 | 0.010 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2000 | 32 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2002 | 381 | 0.010 |
Why?
|
| Linear Models | 1 | 2011 | 5952 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 1081 | 0.010 |
Why?
|
| Fibrosis | 1 | 2007 | 2029 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2002 | 374 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 25043 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 56430 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 534 | 0.010 |
Why?
|
| Neurons | 1 | 1998 | 9338 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2002 | 1472 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1730 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2000 | 689 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 916 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2000 | 1137 | 0.010 |
Why?
|
| Cell Line | 2 | 2002 | 15997 | 0.010 |
Why?
|
| Chloride Channels | 1 | 1995 | 227 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 21746 | 0.010 |
Why?
|
| Mutation | 1 | 1998 | 29786 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 2118 | 0.010 |
Why?
|
| Lung | 1 | 2011 | 9856 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1998 | 1767 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 9734 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 85781 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5751 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1998 | 19229 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2000 | 3748 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 8949 | 0.010 |
Why?
|
| Homeostasis | 1 | 2000 | 3340 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 24260 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7722 | 0.000 |
Why?
|
| Cell Division | 1 | 1995 | 4568 | 0.000 |
Why?
|
| Mice | 2 | 2005 | 81183 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1992 | 1951 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1992 | 1826 | 0.000 |
Why?
|
| Menopause | 1 | 1992 | 1626 | 0.000 |
Why?
|
| Bipolar Disorder | 1 | 1992 | 5027 | 0.000 |
Why?
|